PORTOLA PHARMACEUTICALS INC's ticker is PTLA and the CUSIP is 737010108. A total of 224 filers reported holding PORTOLA PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 1.84 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $7,989,000 | -27.1% | 300,000 | +33.3% | 1.70% | -33.9% |
| Q4 2017 | $10,953,000 | -67.5% | 225,000 | -62.5% | 2.57% | -63.3% |
| Q2 2017 | $33,702,000 | +330.0% | 600,000 | +200.0% | 7.00% | +379.5% |
| Q1 2017 | $7,838,000 | +174.4% | 200,000 | +42.9% | 1.46% | -9.6% |
| Q1 2016 | $2,856,000 | -75.9% | 140,000 | -39.1% | 1.62% | -66.6% |
| Q4 2015 | $11,834,000 | +1010.1% | 230,000 | +820.0% | 4.84% | +909.4% |
| Q3 2015 | $1,066,000 | -86.2% | 25,000 | -85.3% | 0.48% | -80.9% |
| Q2 2015 | $7,744,000 | -43.3% | 170,000 | -52.8% | 2.51% | +2.1% |
| Q1 2015 | $13,666,000 | +221.7% | 360,000 | +140.0% | 2.46% | +20.6% |
| Q4 2014 | $4,248,000 | +46.1% | 150,000 | +30.4% | 2.04% | +29.2% |
| Q3 2014 | $2,907,000 | – | 115,000 | – | 1.58% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fernwood Investment Management, LLC | 228,873 | $7,475,000 | 4.17% |
| PFM Health Sciences, LP | 5,326,671 | $173,969,000 | 3.54% |
| Marcus Capital, LLC | 22,950 | $750,000 | 2.76% |
| Partner Investment Management, L.P. | 72,284 | $2,361,000 | 2.55% |
| CADIAN CAPITAL MANAGEMENT, LP | 1,240,944 | $40,529,000 | 2.19% |
| HARVEY CAPITAL MANAGEMENT INC | 158,580 | $5,179,000 | 1.94% |
| SECTORAL ASSET MANAGEMENT INC | 498,412 | $16,278,000 | 1.78% |
| Everett Capital Advisors UK LLP | 551,173 | $18,001,000 | 1.52% |
| ROSENBLUM SILVERMAN SUTTON S F INC /CA | 125,210 | $4,089,000 | 1.46% |
| Atika Capital Management LLC | 113,000 | $3,691,000 | 1.26% |